Advanced Biomed Inc. Common Stock Asset Resilience Ratio
Advanced Biomed Inc. Common Stock asset resilience ratio. Advanced Biomed Inc. Common Stock (ADVB) has an Asset Resilience Ratio of 0.09% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read ADVB total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Advanced Biomed Inc. Common Stock (None–None)
Asset resilience ratio of Advanced Biomed Inc. Common Stock from None to None. This chart shows how Advanced Biomed Inc. Common Stock's Asset Resilience Ratio has changed over time. See ADVB free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Advanced Biomed Inc. Common Stock's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Advanced Biomed Inc. Common Stock.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $9.99K | 0.09% |
| Total Liquid Assets | $9.99K | 0.09% |
Asset Resilience Insights
- Limited Liquidity: Advanced Biomed Inc. Common Stock maintains only 0.09% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Advanced Biomed Inc. Common Stock Industry Peers by Asset Resilience Ratio
Compare Advanced Biomed Inc. Common Stock's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sotera Health Co
NASDAQ:SHC |
Diagnostics & Research | 0.01% |
|
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB |
Diagnostics & Research | 13.43% |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882 |
Diagnostics & Research | 0.14% |
|
Healius Ltd
AU:HLS |
Diagnostics & Research | 0.06% |
|
Green Cross Lab Cell Corporation
KQ:144510 |
Diagnostics & Research | 0.18% |
|
RHYTHM Biosciences Ltd
AU:RHY |
Diagnostics & Research | 2.74% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
Advanced Biomed Inc. Common Stock Asset Resilience Ratio by Year (None–None)
Advanced Biomed Inc. Common Stock asset resilience ratio by year from None to None. The table below shows the annual Asset Resilience Ratio data for Advanced Biomed Inc. Common Stock.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| No yearly data available. | ||||
About Advanced Biomed Inc. Common Stock
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagul… Read more